MedTrace Logo

Prospective Randomized Endovascular Therapy in Multiple Sclerosis - PREMiSE

NCT01450072 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-06-18

Study results available
· View outcomes & findings →

Summary

The Departments of Neurology and Neurosurgery are conducting this research study to evaluate the safety and effectiveness of intravascular angioplasty for the treatment of venous narrowing in the treatment of Multiple Sclerosis (MS).

Conditions

Interventions

DEVICE

Selective Venography followed by therapeutic balloon angioplasty

Venography followed by therapeutic balloon angioplasty

OTHER

Control arm

Venography and sham angioplasty

Sponsors & Collaborators

  • State University of New York at Buffalo

    lead OTHER

Principal Investigators

  • Adnan Siddiqui, MD, PhD · University at Buffalo Neurosurgery

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2011-12-31
Completion
2012-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01450072 on ClinicalTrials.gov